Leuphasyl vs SNAP-8
A side-by-side research comparison of Leuphasyl and SNAP-8 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Leuphasyl | SNAP-8 |
|---|---|---|
| Full name | Leuphasyl (Pentapeptide-18) | SNAP-8 (Acetyl Octapeptide-3) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Binds enkephalin receptors on neuronal membranes, reducing calcium influx and neurotransmitter release at the presynaptic level. Works upstream of argireline. | More effectively competes with SNAP-25 for SNARE complex incorporation due to longer sequence, providing greater vesicle-membrane fusion inhibition. |
| Molecular weight | 599.7 Da | 1,075 Da |
| Half-life | 6-10 hours (topical) | 8-14 hours (topical) |
| Bioavailability | Moderate (topical) | Moderate (topical) |
| Typical dose | 3-5% solution | 3-10% solution |
| Frequency | 2x daily | 2x daily |
| Route | Topical | Topical |
Leuphasyl reported benefits
- Complements argireline action
- Reduces muscle tension
- Smooths expression lines
- Gentle mechanism
SNAP-8 reported benefits
- Superior to argireline
- Deeper wrinkle reduction
- Prevents expression lines
- Good skin penetration
Related comparisons
Research and educational reference only. Not medical advice.